The loss of NF1 function is seen as an early step in the development of neurofibromas, which then may progress to MPNST with mutations in other tumour suppressor genes such as TP53 and CDKN2A28. This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.